Join the club for FREE to access the whole archive and other member benefits.

Ben Larman

Associate Professor at Johns Hopkins School of Medicine, Scientific Founder and CSO at Infinity Bio

Dr. Larman trained in physics and bioengineering at UC Berkeley, and then in genetics and materials science at the Harvard-MIT graduate program in health sciences and technology. Here he developed Phage ImmunoPrecipitation Sequencing in the lab of Steve Elledge. He then did his postdoc at Scripps in the laboratory of Pete Schultz, where he combined multiplexed molecular assays with liquid handling automation. Dr. Larman joined the faculty at Johns Hopkins in 2014, where he is currently an Associate Professor in the Immunology Division of the Pathology Department. His laboratory develops and deploys novel molecular assays to advance our understanding of targeted immune responses. Dr. Larman trains students and postdocs from chemical, biological and engineering backgrounds to develop new techniques and analytical approaches. Alongside his academic career, Dr. Larman also works to translate technological innovations through company formation. 

Visit website: https://profiles.hopkinsmedicine.org/provider/ben-larman/2777925

 h-benjamin-larman-5351514

 larmanlab

See also: Academia Johns Hopkins School of Medicine - Public Research university.

Details last updated 17-Jan-2025

Ben Larman is also referenced in the following:

Alchemab Therapeutics

Biotechnology company